Abacus Global Management (NASDAQ: ABL) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide. Contact: Investor Relations Robert F. Phil ...

Core Viewpoint - Abacus Global Management, Inc. is under investigation for potential securities fraud and unlawful business practices, following allegations of manipulating financial reporting to appear more profitable than it is [1][2]. Group 1: Investigation and Allegations - An investigation is being conducted on behalf of investors of Abacus Global Management regarding possible securities fraud by the company and its officers or directors [1]. - A report by Morpheus Research claims that Abacus has altered its portfolio valuation methodology to inflate profitability and uses questionable life expectancy calculations, raising concerns about the integrity of its financial practices [2]. Group 2: Market Reaction - Following the news of the investigation and the allegations, Abacus's stock price experienced a significant decline, falling by $1.64 per share, or 21.47%, closing at $6.00 per share on June 5, 2025 [3].

Core Viewpoint - Abacus Global Management, Inc. has filed a lawsuit against Coventry First LLC and its Chairman Alan Buerger, alleging a systematic campaign to disseminate false and misleading information aimed at damaging Abacus's reputation and market position [1][2][3]. Group 1: Allegations and Lawsuit Details - The lawsuit claims that Coventry and Buerger engaged in a multi-year effort to undermine Abacus's valuation practices, attempting to convince the market that Abacus overpays policyholders, leading to an overvaluation of its assets [3][4]. - Abacus asserts that Coventry's actions constitute tortious interference and defamation, as they have resorted to damaging Abacus's reputation instead of competing fairly [4]. - The lawsuit highlights that Abacus's financial practices are transparent and compliant with GAAP, contradicting Coventry's claims about Abacus's valuation methods [8][9]. Group 2: Impact of False Claims - Following a June 4, 2025 interview with Buerger, Abacus's stock dropped over 21%, resulting in a loss of more than $200 million in market capitalization due to the dissemination of false information [9][10]. - Abacus alleges that Coventry's campaign has caused substantial harm to its reputation, customer base, and investor relationships, with the company seeking hundreds of millions in damages [11][12]. - The lawsuit also points out that Coventry has a history of unsavory practices, including bid-rigging and involvement in illegal life insurance practices, which further undermines its credibility [11][12]. Group 3: Role of Short Seller - Morpheus Research is identified as a partner in disseminating Coventry's defamatory statements, with the short report released shortly after Buerger's interview, amplifying the false claims about Abacus [10][11]. - The lawsuit alleges that Morpheus's report echoed Coventry's misleading statements, contributing to the confusion among investors and market analysts [10][11].

Core Viewpoint - Abacus Global Management, Inc. has initiated an exchange offer and consent solicitation to simplify its capital structure and mitigate the potential dilutive impact of outstanding warrants [1][2]. Group 1: Exchange Offer Details - The company is offering 0.23 shares of common stock for each warrant tendered, with a total of up to 4,743,381 shares available for exchange [2]. - The offering period will last until July 29, 2025, with the possibility of extension [2]. - Holders can withdraw their tendered warrants at any time before the expiration date [2]. Group 2: Consent Solicitation - The company is soliciting consents to amend the warrant agreement, allowing for an exchange ratio of 0.207 shares per warrant, which is 10% less than the current offer [3]. - Approximately 25% of public warrants and 94% of private placement warrants have agreed to participate in the offer and consent to the amendment [3]. - An additional 25% consent from public warrant holders is needed for the amendment to be adopted [3]. Group 3: Current Capital Structure - As of June 30, 2025, there are 97,867,821 shares of common stock and 20,623,395 warrants outstanding [5]. - If all warrants are exchanged, the total shares outstanding would increase to 102,611,202, representing a 5% increase, with no warrants remaining [5]. Group 4: Regulatory Information - The offer and consent solicitation are conducted under a prospectus and Schedule TO filed with the SEC [4]. - D.F. King & Co., Inc. is the information agent, while Continental Stock Transfer & Trust Company serves as the exchange agent [6].

Core Viewpoint - Abacus Global Management, Inc. plans to conduct an exchange offer and consent solicitation for its outstanding public and private placement warrants, allowing holders to exchange warrants for shares of common stock [1][2]. Group 1: Exchange Offer Details - Each outstanding warrant is exercisable for one common share at a price of $11.50 per share [2]. - The company intends to offer 0.23 shares of common stock in exchange for each outstanding warrant tendered [2]. - The company will also solicit consents to amend the Warrant Agreement, allowing for an exchange ratio of 0.207 shares per warrant, which is 10% less than the initial offer [2]. Group 2: Regulatory and Procedural Aspects - The company expects to commence the Offer after filing a Form S-4 registration statement detailing the terms of the Offer [3].

Core Viewpoint - Abacus Global Management is facing significant pressure as its stock price has dropped over 36% in the past month due to serious allegations from Morpheus Research regarding financial misconduct and questionable accounting practices [1][5]. Group 1: Allegations and Investigations - Morpheus Research, a new investigative group with ties to Hindenburg Research, published reports accusing Abacus of manipulating its life settlements portfolio through aggressive accounting practices, leading to inflated asset values and "fake revenue" [3][4]. - Hagens Berman, a prominent law firm, has initiated its own investigation into the claims made by Morpheus Research, urging affected shareholders to report their financial losses [2][6]. - The scrutiny intensified after Morpheus's follow-up report alleged inconsistencies in Abacus's rebuttal and introduced claims of undisclosed related-party transactions [4]. Group 2: Company Response and Stock Performance - In response to the allegations, Abacus retained independent actuarial firm Lewis & Ellis to review its balance sheet and reassure investors of compliance with accounting standards [4]. - Despite the company's efforts, including a $20 million share repurchase program aimed at restoring investor confidence, the stock has continued to trade near its 52-week low [5][6]. - The stock experienced a sharp 20% drop in a single day following the initial report from Morpheus [3].

ORLANDO, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL), a leader in the alternative asset management space, announced the public launch of their new corporate-focused commercial campaign on June 12, 2025, at their Investor Day and Longevity Summit held at Nasdaq in New York City. The campaign is centered around Abacus' positioning as a visionary leader in longevity-based asset management. In the commercial, Abacus CEO Jay Jackson depicts the ...

Investor Day & Longevity Summit June 12, 2025 abacusgm.com Disclaimer General. This presentation (this "Presentation") is provided solely for informational purposes. This Presentation is subject to update, completion, revision, verification and further amendment without notice. None of Abacus Global Management, Inc. (the "Company", "Abacus", Abacus Global Management", "we", "our", or "us") or its affiliates has authorized anyone to provide interested parties with additional or different information. The inf ...

Core Viewpoint - Abacus Global Management, Inc. is facing significant scrutiny and a decline in share price due to allegations of improper accounting practices, as detailed in two critical reports from Morpheus Research within a week [1][3][5]. Group 1: Allegations and Reports - Morpheus Research published an initial report on June 4, 2025, alleging that Abacus engaged in an "accounting scheme" by using "mark-to-model" accounting and underestimating life expectancies, leading to the creation of "fake revenue" [3][4]. - The second report from Morpheus, released on June 12, 2025, escalated the allegations by presenting new evidence of undisclosed related-party dealings and questioning the independence of the actuarial firm Lewis & Ellis, which Abacus claimed had vetted its asset valuations [5][6]. Group 2: Market Reaction - Following the initial Morpheus report, Abacus's shares experienced a decline of over 20% in a single trading day [4]. - The ongoing investigations and negative reports have led to a continued sharp decline in Abacus's share price, raising concerns among investors [6]. Group 3: Company Response - In response to the allegations, Abacus published a rebuttal on June 10, 2025, asserting that it had retained Lewis & Ellis to validate its balance sheet, claiming the firm has a "sterling reputation" [4]. - However, Morpheus's follow-up report indicated that Abacus's rebuttal was inadequate and contradicted its own SEC filings, further intensifying scrutiny on the company's financial practices [5].

Summary of Abacus Global Management Conference Call Company Overview - **Company**: Abacus Global Management - **Industry**: Asset Management, Life Insurance Policies Key Points and Arguments 1. **Business Model Evolution**: Abacus is expanding from life insurance policy sourcing to asset management and private wealth management, leveraging lifespan data and technology [1][7][10] 2. **Growth Strategy**: The company aims to control its destiny through a diversified business model, focusing on four main divisions: Abacus Asset Group, Abacus Life Solutions, ABL Tech, and Abacus Wealth Advisors [27][28][45] 3. **Financial Performance**: - Q1 2025 revenue reached $44.1 million, a 105% increase year-over-year - Adjusted net income was $17.3 million, up 158% from the previous year - Adjusted EBITDA was $24.5 million, reflecting a 111% growth [29][30][34] 4. **Capital Deployment**: $125.9 million was deployed for policy purchases through Abacus Life Solutions, with $3.1 billion in assets under management [31][32] 5. **Market Position**: Abacus is positioned as a leader in the alternative asset management space, focusing on longevity and technology-driven solutions [28][45] 6. **Acquisition Strategy**: The acquisition of Carlisle Management Company added $2 billion in assets under management and is expected to generate $30 million in recurring management fees annually [48][49] 7. **Client Base and Partnerships**: The company has established partnerships with over 30,000 independent brokers and has a growing consumer direct division fueled by digital marketing [66][67] 8. **Future Guidance**: The company projects adjusted net income for 2025 to be between $70 million and $78 million, with a goal of reaching $10 billion in assets under management in the coming years [56] Additional Important Insights 1. **Technological Integration**: ABL Tech is enhancing the company's data analytics capabilities, which supports better decision-making and risk management [51][52] 2. **Demographic Trends**: The aging population and increasing need for retirement solutions are driving demand for Abacus's services [68] 3. **Regulatory Compliance**: Abacus is now regulated by both the SEC in the U.S. and the CSSF in Luxembourg, enhancing transparency and product quality [82][83] 4. **Social Responsibility**: The company has received ESG certification, emphasizing its commitment to socially responsible investment practices [83] 5. **Market Opportunities**: There is an estimated $223 billion in life insurance policies available in the secondary market, presenting significant growth potential for Abacus [66][69] This summary encapsulates the key points discussed during the conference call, highlighting Abacus Global Management's strategic direction, financial performance, and market opportunities.